Medicare Enrolled
Dr. Alexander Reyzelman, DPM
Foot & Ankle Surgery Podiatrist · San Francisco, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reyzelman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reyzelman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reyzelman
Dr. Alexander Reyzelman is a foot & ankle surgery podiatrist in San Francisco, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Reyzelman performed 1,324 Medicare services across 734 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reyzelman received a total of $222,057 from 49 pharmaceutical and/or device companies across 306 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in foot & ankle surgery podiatrist. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reyzelman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 50% volume in CA
$222,057 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,324
Medicare services
Top 50% in CA for foot & ankle surgery podiatrist
734
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~70 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
348 | $82 | $324 |
| Vein wound compression bandage application, lower leg, ankle, and foot Application of compression bandages to the lower leg, ankle, and foot to manage vein-related wounds. |
148 | $96 | $399 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
110 | $72 | $239 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
109 | $114 | $456 |
| Strapping, unna boot | 72 | $67 | $250 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
67 | $33 | $136 |
| Skin and tissue removal, 20 sq cm or less This procedure involves the surgical excision of skin and underlying tissue from an area measuring 20 square centimeters or smaller. |
62 | $126 | $497 |
| Toenail/fingernail removal, 6+ nails Surgical removal of six or more fingernails or toenails. This procedure involves the excision of multiple nails during a single session. |
62 | $38 | $162 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
52 | $118 | $451 |
| Skin substitute graft application, 25 sq cm or less Application of a skin substitute graft to a wound on the trunk, arms, or legs covering 25 square centimeters or less. |
48 | $151 | $578 |
| Functional capacity test, per 15 minutes A test or measurement to assess functional capacity. The service is billed for each 15-minute increment. |
48 | $29 | $108 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
48 | $87 | $397 |
| Removal of noncancer thickened skin growth, 1 growth This procedure involves the removal of a single benign, thickened skin growth. It is a minor surgical intervention to eliminate the lesion. |
38 | $67 | $285 |
| Removal of thickened skin growths, 2-4 This procedure involves the removal of two to four benign, thickened skin growths. It is a minor surgical intervention to eliminate non-cancerous skin lesions. |
34 | $76 | $324 |
| Toenail/fingernail removal, 1-5 nails This procedure involves the removal of one to five fingernails or toenails. |
25 | $30 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $127 | $586 |
| Wound tissue removal, 20 sq cm or less This procedure involves the removal of tissue from a wound area measuring 20 square centimeters or less. |
16 | $94 | $392 |
| Trimming of dystrophic nails Trimming of dystrophic nails, any number |
15 | $20 | $90 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$222,057
Total received (2018-2024)
Avg $31,722/year across 7 years
Top 1% in CA for foot & ankle surgery podiatrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
306
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$120,007 (54.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$80,751 (36.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,030 (5.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,270 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$103,684
2023
$1,275
2022
$19,331
2021
$542
2020
$1,102
2019
$4,944
2018
$91,179
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ConvaTec Inc.
$101,643
Orthofix Medical, Inc.
$468
Alafair Biosciences, Inc.
$453
Stryker Corporation
$297
Smith+Nephew, Inc.
$188
Tactile Systems Technology Inc
$176
EXACTECH, INC.
$171
MIMEDX Group, Inc.
$117
DePuy Synthes Sales Inc.
$86
Aroa Biosurgery Incorporated
$33
Urgo Medical North America, LLC
$28
Integra LifeSciences Corporation
$24
Top 3 companies account for 98.9% of 2024 payments
All-time payments by company (2018-2024) ›
ConvaTec Inc.
$101,698
Osiris Therapeutics Inc.
$83,907
Smith+Nephew, Inc.
$21,332
Ferring Pharmaceuticals Inc.
$9,873
Nevro Corp.
$519
Orthofix Medical, Inc.
$468
Alafair Biosciences, Inc.
$453
TREACE MEDICAL CONCEPTS, INC.
$401
Stryker Corporation
$297
PolarityTE, Inc.
$256
Musculoskeletal Transplant Foundation Inc.
$255
Tactile Systems Technology Inc
$176
Biocomposites Inc
$176
EXACTECH, INC.
$171
Takeda Pharmaceuticals U.S.A., Inc.
$153
CROSSROADS EXTREMITY SYSTEMS, LLC
$152
TissueTech, Inc.
$148
Janssen Pharmaceuticals, Inc
$121
MIMEDX Group, Inc.
$117
Melinta Therapeutics, LLC
$117
Merck Sharp & Dohme Corporation
$102
Ortho Dermatologics, a division of Bausch Health US, LLC
$91
DePuy Synthes Sales Inc.
$86
Amgen Inc.
$83
ETS Wound Care LLC
$80
Evolution Surgical, Inc
$68
Integra LifeSciences Corporation
$62
ORGANOGENESIS INC.
$60
Aroa Biosurgery Incorporated
$59
Derma Sciences, Inc.
$52
Melinta Therapeutics, Inc.
$46
Paragon 28, Inc.
$44
Organogenesis Inc.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
Wright Medical Technology, Inc.
$37
Amniox Medical, Inc.
$30
HARTMANN USA, INC.
$29
Urgo Medical North America, LLC
$28
Resmed Corp
$28
Milliken Healthcare Products, LLC
$26
Novo Nordisk Inc
$25
Bioventus LLC
$23
AbbVie Inc.
$22
Medline Industries, Inc.
$20
GRT US Holding, Inc.
$19
KCI USA, Inc.
$19
Smith & Nephew, Inc.
$18
ABBVIE INC.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 93.2% of all-time payments
Associated products mentioned in payments ›
3M Coban · AIR 11 · AMNIOEXCEL · AQUACEL AG · AQUACEL AG+ · AQUACEL FOAM · AccelStim · Amitiza · Baxdela · COLLAGENASE SANTYL · CROSSCHECK · DALVANCE · Dexilant · EUFLEXXA · EVENITY · Exogen Ultrasound Bone Healing System · Flexitouch Plus · GRAFIX · GRAFIX PL · GRAFIX/GRAFIXPL/STRAVIX · Grafix PL PRIME · GrafixPL · GrafixPL PRIME · INFINITY · INNOVAMATRIX AC · INVOKANA · Integra · IoPlex Iodophor Foam Dressings · JANUVIA · JARDIANCE · JUBLIA · Kimyrsa · LAPIPLASTY SYSTEM · MIRRAGEN ADVANCED WOUND MATRIX · MOTOBAND CP · Medical Implant · Motegrity · NEOX · OMNIGRAFT · Omnia · Orbactiv · Ozempic · PICO · PROSTEP MICA · Phantom Metatarsal Shortening · Prokera · Prolia · Puraply · Puraply Antimicrobial · Qutenza · RENASYS · RENASYS GO · SALVATION · STRAVIX · Santyl · Senza · SkinTE · Stimulan · Stravix · URGOK2 · Uloric · VANTAGE · VersaWrap · XARELTO · XIFAXAN · Zetuvit Plus
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 1% for foot & ankle surgery podiatrist in CA.
Geographic Context
Foot & ankle surgery podiatrists within 10 mi
125
Per 100K population
14.9
County median income
$141,446
Nearest hospital
KAISER FOUNDATION HOSPITAL - SAN FRANCISCO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reyzelman is a clinical cardiology specialist, with moderate Medicare volume, with mixed engagement industry engagement in the top 1% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reyzelman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Reyzelman performed 348 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reyzelman receive payments from pharmaceutical companies?
Yes. Dr. Reyzelman received a total of $222,057 from 49 companies across 306 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reyzelman's costs compare to other foot & ankle surgery podiatrists in San Francisco?
Dr. Reyzelman's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reyzelman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Foot & Ankle Surgery Podiatrists in San Francisco
Browse foot & ankle surgery podiatrists in San Francisco ranked by procedure volume and transparency data.
Highest volume
Top Foot & Ankle Surgery Podiatrists in CA
Foot & ankle surgery podiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Foot & Ankle Surgery Podiatrists in CA
Which CA foot & ankle surgery podiatrists receive the most from drug and device companies.
By company
ConvaTec Inc. Payments to Doctors
See all physicians who received payments from ConvaTec Inc.
By company
Osiris Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Osiris Therapeutics Inc.
By company
Smith+Nephew, Inc. Payments to Doctors
See all physicians who received payments from Smith+Nephew, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology